US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 767.760
  • +10.220+1.35%
Close Dec 20 16:00 ET
  • 780.990
  • +13.230+1.72%
Post 20:01 ET
728.85BMarket Cap83.00P/E (TTM)

Eli Lilly and Co Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
69.53%3.71B
132.03%1.47B
-32.62%1.17B
-44.10%4.24B
-118.76%-311.9M
-1.23%2.19B
-46.60%631.9M
-31.41%1.73B
2.98%7.59B
-26.48%1.66B
Net income from continuing operations
1,790.42%970.3M
68.27%2.97B
66.77%2.24B
-16.08%5.24B
13.01%2.19B
-103.95%-57.4M
85.11%1.76B
-29.32%1.34B
11.88%6.24B
12.26%1.94B
Operating gains losses
88.09%-213.1M
140.12%158M
-211.27%-15.8M
-804.14%-1.86B
54.15%-146M
-5,029.48%-1.79B
-44.94%65.8M
-96.67%14.2M
2,252.68%263.5M
-159.07%-318.4M
Depreciation and amortization
13.58%466.8M
13.13%414.4M
10.57%400.6M
0.32%1.53B
3.39%387.7M
13.25%411M
4.99%366.3M
-16.85%362.3M
-1.62%1.52B
-15.86%375M
Deferred tax
49.09%-429.8M
-133.73%-1.01B
50.13%-279M
-7.13%-2.34B
-4,967.31%-506.2M
21.14%-844.3M
30.29%-431.1M
-10.42%-559.4M
-172.37%-2.19B
111.24%10.4M
Other non cash items
-19.26%2.79B
126.98%122.4M
49.69%409.1M
198.97%4.1B
109.32%814.9M
716.78%3.46B
-226.49%-453.6M
37.89%273.3M
-19.30%1.37B
-43.95%389.3M
Change In working capital
-101.24%-9.8M
-66.52%-1.4B
-1,167.15%-1.75B
-381,775.00%-3.06B
-284.88%-3.17B
-14.48%793.3M
-1,102.00%-840.2M
578.43%164.1M
99.92%-800K
-77.44%-824.2M
-Change in receivables
----
----
----
-718.09%-2.45B
----
----
----
----
76.56%-299.6M
----
-Change in inventory
----
----
----
-137.62%-1.43B
----
----
----
----
-154.22%-599.7M
----
-Change in payables and accrued expense
----
----
----
152.62%4.27B
----
----
----
----
266.90%1.69B
----
-Change in other current assets
----
----
----
-335.21%-3.45B
----
----
----
----
-152.36%-793.5M
----
Cash from discontinued investing activities
Operating cash flow
69.53%3.71B
132.03%1.47B
-32.62%1.17B
-44.10%4.24B
-118.76%-311.9M
-1.23%2.19B
-46.60%631.9M
-31.41%1.73B
2.98%7.59B
-26.48%1.66B
Investing cash flow
Cash flow from continuing investing activities
-30.00%-4B
-378.92%-2.2B
-70.96%-1.18B
-90.08%-7.15B
-209.94%-2.92B
-222.46%-3.08B
44.45%-459.1M
33.62%-688.8M
-31.23%-3.76B
-94.86%-943.5M
Net PPE purchase and sale
-39.20%-1.35B
-65.92%-1.22B
-47.54%-986.3M
-85.92%-3.45B
-113.82%-1.07B
-57.21%-970.3M
-98.98%-738.2M
-82.95%-668.5M
-41.57%-1.85B
-71.83%-500.7M
Net intangibles purchase and sale
-60.47%-2.29B
-81.45%-178M
58.94%-96.5M
-126.06%-2.34B
-438.00%-580.5M
-4,716.83%-1.43B
77.84%-98.1M
54.42%-235M
-128.72%-1.04B
-1,448.75%-107.9M
Net business purchase and sale
--0
----
----
-219.16%-1.04B
---1.04B
--0
----
----
56.22%-327.2M
----
Net investment purchase and sale
-1,020.69%-195M
170.60%56.2M
-116.97%-29.6M
47.25%-128.7M
-420.45%-206.1M
88.10%-17.4M
-127.43%-79.6M
851.72%174.4M
-46.99%-244M
-235.59%-39.6M
Net other investing changes
74.51%-169.8M
-79.07%95.6M
-261.79%-65.2M
36.50%-191.9M
-171.47%-22.8M
-199.01%-666.2M
1,966.97%456.8M
130.21%40.3M
-57.64%-302.2M
116.88%31.9M
Cash from discontinued investing activities
Investing cash flow
-30.00%-4B
-378.92%-2.2B
-70.96%-1.18B
-90.08%-7.15B
-209.94%-2.92B
-222.46%-3.08B
44.45%-459.1M
33.62%-688.8M
-31.23%-3.76B
-94.86%-943.5M
Financing cash flow
Cash flow from continuing financing activities
-63.06%211.3M
250.52%1.56B
-175.50%-311.3M
164.65%3.5B
410.56%3.54B
145.28%572M
-735.41%-1.03B
114.32%412.3M
-30.87%-5.41B
25.23%-1.14B
Net issuance payments of debt
17.57%1.88B
--2.74B
-49.29%1.25B
14,051.45%8.65B
1,988.37%4.59B
524.31%1.6B
--0
1,269.44%2.46B
-112.37%-62M
-9,257.69%-243.3M
Net common stock issuance
---446.1M
--0
--0
50.00%-750M
--0
--0
--0
50.00%-750M
-20.00%-1.5B
--0
Cash dividends paid
-15.18%-1.17B
-15.19%-1.17B
-14.94%-1.17B
-15.09%-4.07B
-15.12%-1.02B
-15.19%-1.02B
-15.17%-1.02B
-14.87%-1.02B
-14.55%-3.54B
-14.37%-884.4M
Net other financing activities
-595.59%-47.3M
48.72%-8M
-38.72%-389.8M
-8.45%-335M
-130.66%-31.6M
-30.77%-6.8M
-105.26%-15.6M
0.50%-281M
-4.39%-308.9M
-2,183.33%-13.7M
Cash from discontinued financing activities
Financing cash flow
-63.06%211.3M
250.52%1.56B
-175.50%-311.3M
164.65%3.5B
410.56%3.54B
145.28%572M
-735.41%-1.03B
114.32%412.3M
-30.87%-5.41B
25.23%-1.14B
Net cash flow
Beginning cash position
19.64%3.22B
-30.62%2.46B
36.36%2.82B
-45.87%2.07B
-9.04%2.38B
2.73%2.69B
44.19%3.55B
-45.87%2.07B
4.41%3.82B
-30.91%2.62B
Current changes in cash
74.45%-81.5M
195.63%823M
-122.21%-322.9M
136.81%583M
173.07%308.5M
-16,689.47%-319M
-469.20%-860.6M
204.39%1.45B
-531.46%-1.58B
-268.21%-422.2M
Effect of exchange rate changes
4,181.13%226.9M
-747.83%-59.6M
-243.15%-35.5M
200.60%168.6M
200.86%129.3M
247.22%5.3M
113.26%9.2M
-26.19%24.8M
18.52%-167.6M
41.91%-128.2M
End cash Position
41.51%3.37B
19.64%3.22B
-30.62%2.46B
36.36%2.82B
36.36%2.82B
-9.04%2.38B
2.73%2.69B
44.19%3.55B
-45.87%2.07B
-45.87%2.07B
Free cash flow
74.67%-458.9M
131.02%63.4M
-89.94%83.2M
-168.52%-3.15B
-291.68%-1.96B
-215.79%-1.81B
-155.29%-204.4M
-49.63%827.1M
-14.61%4.6B
-41.89%1.02B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 69.53%3.71B132.03%1.47B-32.62%1.17B-44.10%4.24B-118.76%-311.9M-1.23%2.19B-46.60%631.9M-31.41%1.73B2.98%7.59B-26.48%1.66B
Net income from continuing operations 1,790.42%970.3M68.27%2.97B66.77%2.24B-16.08%5.24B13.01%2.19B-103.95%-57.4M85.11%1.76B-29.32%1.34B11.88%6.24B12.26%1.94B
Operating gains losses 88.09%-213.1M140.12%158M-211.27%-15.8M-804.14%-1.86B54.15%-146M-5,029.48%-1.79B-44.94%65.8M-96.67%14.2M2,252.68%263.5M-159.07%-318.4M
Depreciation and amortization 13.58%466.8M13.13%414.4M10.57%400.6M0.32%1.53B3.39%387.7M13.25%411M4.99%366.3M-16.85%362.3M-1.62%1.52B-15.86%375M
Deferred tax 49.09%-429.8M-133.73%-1.01B50.13%-279M-7.13%-2.34B-4,967.31%-506.2M21.14%-844.3M30.29%-431.1M-10.42%-559.4M-172.37%-2.19B111.24%10.4M
Other non cash items -19.26%2.79B126.98%122.4M49.69%409.1M198.97%4.1B109.32%814.9M716.78%3.46B-226.49%-453.6M37.89%273.3M-19.30%1.37B-43.95%389.3M
Change In working capital -101.24%-9.8M-66.52%-1.4B-1,167.15%-1.75B-381,775.00%-3.06B-284.88%-3.17B-14.48%793.3M-1,102.00%-840.2M578.43%164.1M99.92%-800K-77.44%-824.2M
-Change in receivables -------------718.09%-2.45B----------------76.56%-299.6M----
-Change in inventory -------------137.62%-1.43B-----------------154.22%-599.7M----
-Change in payables and accrued expense ------------152.62%4.27B----------------266.90%1.69B----
-Change in other current assets -------------335.21%-3.45B-----------------152.36%-793.5M----
Cash from discontinued investing activities
Operating cash flow 69.53%3.71B132.03%1.47B-32.62%1.17B-44.10%4.24B-118.76%-311.9M-1.23%2.19B-46.60%631.9M-31.41%1.73B2.98%7.59B-26.48%1.66B
Investing cash flow
Cash flow from continuing investing activities -30.00%-4B-378.92%-2.2B-70.96%-1.18B-90.08%-7.15B-209.94%-2.92B-222.46%-3.08B44.45%-459.1M33.62%-688.8M-31.23%-3.76B-94.86%-943.5M
Net PPE purchase and sale -39.20%-1.35B-65.92%-1.22B-47.54%-986.3M-85.92%-3.45B-113.82%-1.07B-57.21%-970.3M-98.98%-738.2M-82.95%-668.5M-41.57%-1.85B-71.83%-500.7M
Net intangibles purchase and sale -60.47%-2.29B-81.45%-178M58.94%-96.5M-126.06%-2.34B-438.00%-580.5M-4,716.83%-1.43B77.84%-98.1M54.42%-235M-128.72%-1.04B-1,448.75%-107.9M
Net business purchase and sale --0---------219.16%-1.04B---1.04B--0--------56.22%-327.2M----
Net investment purchase and sale -1,020.69%-195M170.60%56.2M-116.97%-29.6M47.25%-128.7M-420.45%-206.1M88.10%-17.4M-127.43%-79.6M851.72%174.4M-46.99%-244M-235.59%-39.6M
Net other investing changes 74.51%-169.8M-79.07%95.6M-261.79%-65.2M36.50%-191.9M-171.47%-22.8M-199.01%-666.2M1,966.97%456.8M130.21%40.3M-57.64%-302.2M116.88%31.9M
Cash from discontinued investing activities
Investing cash flow -30.00%-4B-378.92%-2.2B-70.96%-1.18B-90.08%-7.15B-209.94%-2.92B-222.46%-3.08B44.45%-459.1M33.62%-688.8M-31.23%-3.76B-94.86%-943.5M
Financing cash flow
Cash flow from continuing financing activities -63.06%211.3M250.52%1.56B-175.50%-311.3M164.65%3.5B410.56%3.54B145.28%572M-735.41%-1.03B114.32%412.3M-30.87%-5.41B25.23%-1.14B
Net issuance payments of debt 17.57%1.88B--2.74B-49.29%1.25B14,051.45%8.65B1,988.37%4.59B524.31%1.6B--01,269.44%2.46B-112.37%-62M-9,257.69%-243.3M
Net common stock issuance ---446.1M--0--050.00%-750M--0--0--050.00%-750M-20.00%-1.5B--0
Cash dividends paid -15.18%-1.17B-15.19%-1.17B-14.94%-1.17B-15.09%-4.07B-15.12%-1.02B-15.19%-1.02B-15.17%-1.02B-14.87%-1.02B-14.55%-3.54B-14.37%-884.4M
Net other financing activities -595.59%-47.3M48.72%-8M-38.72%-389.8M-8.45%-335M-130.66%-31.6M-30.77%-6.8M-105.26%-15.6M0.50%-281M-4.39%-308.9M-2,183.33%-13.7M
Cash from discontinued financing activities
Financing cash flow -63.06%211.3M250.52%1.56B-175.50%-311.3M164.65%3.5B410.56%3.54B145.28%572M-735.41%-1.03B114.32%412.3M-30.87%-5.41B25.23%-1.14B
Net cash flow
Beginning cash position 19.64%3.22B-30.62%2.46B36.36%2.82B-45.87%2.07B-9.04%2.38B2.73%2.69B44.19%3.55B-45.87%2.07B4.41%3.82B-30.91%2.62B
Current changes in cash 74.45%-81.5M195.63%823M-122.21%-322.9M136.81%583M173.07%308.5M-16,689.47%-319M-469.20%-860.6M204.39%1.45B-531.46%-1.58B-268.21%-422.2M
Effect of exchange rate changes 4,181.13%226.9M-747.83%-59.6M-243.15%-35.5M200.60%168.6M200.86%129.3M247.22%5.3M113.26%9.2M-26.19%24.8M18.52%-167.6M41.91%-128.2M
End cash Position 41.51%3.37B19.64%3.22B-30.62%2.46B36.36%2.82B36.36%2.82B-9.04%2.38B2.73%2.69B44.19%3.55B-45.87%2.07B-45.87%2.07B
Free cash flow 74.67%-458.9M131.02%63.4M-89.94%83.2M-168.52%-3.15B-291.68%-1.96B-215.79%-1.81B-155.29%-204.4M-49.63%827.1M-14.61%4.6B-41.89%1.02B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-4.61%